System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Publications

Journal Article Ppublish

PubMed: 42741902 DOI: 10.1111/ctr.70680

Impact of Preoperative Cardiac Screening Modality on Cardiovascular Outcomes After Liver Transplantation.

Clin Transplant 40(9):e70680

Authors: Giuseppe Esposito, Marcella Manicardi, Niccolò Bonini, Stefano Di Sandro, Marco Vitolo, Fabrizio Di Benedetto, Giuseppe Boriani, Gian Piero Guerrini

Affiliations

  • Hepato-Pancreato-Biliary Surgery and Liver Transplantation Unit, Policlinico Di Modena, University of Modena and Reggio Emilia, Modena, Italy.
  • Clinical and Experimental Medicine PhD Program, Department of Surgical, Medical and Dental Department of Morphological Sciences Related to Transplant, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy.
  • Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, Policlinico Di Modena, University of Modena and Reggio Emilia, Modena, Italy.

Abstract

INTRODUCTION

Cardiovascular (CV) disease is a leading cause of morbidity and mortality after liver transplantation (LT). Coronary computed tomography angiography (CCTA) has increasingly replaced stress testing (ST) for CV risk assessment in LT candidates with intermediate-to-high CV risk, although comparative evidence remains limited. The primary endpoint was the incidence of post-LT major adverse cardiovascular events (MACE) by CV screening modality; the secondary endpoint was to identify predictors of MACE.

METHODS

This single-center retrospective study included 506 patients who underwent LT between 2018 and 2023. According to CV screening modality, patients were stratified into three groups: no test (low CV risk), ST, or CCTA.

RESULTS

Among 506 LT recipients, 358 (70.8%) presented low CV risk, 57 (11.3%) underwent ST, and 91 (18.0%) CCTA. Compared with ST, CCTA led to higher rates of coronary angiography (14% vs. 31.9%, p = 0.011) and revascularization (0% vs. 15.4%, p < 0.0001). After a median follow-up of 2.5 years [IQR 1.5-3.9], MACE occurred more frequently in CCTA (18.4%) and ST (14%) groups than in low-risk group (9%) (p = 0.041), while no significant difference was observed between CCTA and ST groups (14% vs. 18.4%, p = 0.501). In univariate and multivariate Cox-regression analysis, only age and family history of coronary artery disease were independent predictors of MACE.

CONCLUSIONS

CCTA and ST resulted in comparable post-LT CV outcomes. Although CCTA was associated with a higher number of pre-LT coronary interventions, it was not associated with a lower incidence of MACE, underscoring the need to refine CV risk stratification protocols in LT candidates.

PRACTITIONER POINTS

Currently, there are no international guidelines for cardiovascular screening procedures in LT candidates, leading to variability in practice across different centers and countries. Coronary computed tomography angiography (CCTA) has emerged as a more accurate method than stress testing (ST) in detecting coronary artery disease (CAD) in patients with end-stage liver disease. In the present study, all pre-transplant coronary revascularizations were performed in patients screened with CCTA, while none occurred in the ST group. Despite this, the incidence of post-LT major adverse cardiovascular events (MACE) was similar between groups. In our cohort, revascularizations prompted by CCTA did not significantly reduce post-LT MACE rate. Age and family history of CAD were the only independent predictors of MACE. Our results underscore the need to refine cardiovascular risk stratification protocols for LT candidates.

MeSH

Coronary Angiography, Research Design, Liver Transplantation, Heart Diseases, Coronary Artery Disease, Incidence, Tomography, Exercise Test, Stress, Physiological, Angiography, Arteries, Liver, Transplants, History, Transplantation, Computed Tomography Angiography